臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

	English \| 正體中文 \| 简体中文 \| 總筆數 :0
	造訪人次 : 52896760 線上人數 : 791 教育部委託研究計畫計畫執行:國立臺灣大學圖書館

搜尋範圍

進階搜尋

登入

管理

臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

關於TAIR
	計畫說明

瀏覽
	典藏機構
	作者
	題名
	日期
	統計圖表
	機構即時統計
	學術趨勢

消息
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

著作權
	出版社及期刊政策查詢
	TAIR著作權會議記錄

相關連結
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"hsu c"的相關文件

回到依作者瀏覽
依題名排序	依日期排序

顯示項目 571-580 / 881 (共89頁)
<< < 53 54 55 56 57 58 59 60 61 62 > >>
每頁顯示[10|25|50]項目

機構	日期	題名	作者
臺大學術典藏	2020-04-10T12:15:54Z	Differential Organ-Specific Tumor Response to Immune Checkpoint Inhibitors in Hepatocellular Carcinoma	Shih I.-L.; Hung Y.-P.; Chang C.-J.; Shen Y.-C.; Guo J.-C.; Liu T.-H.; Hsu C.-H.; Cheng A.-L.; Yen C.-J.; Chao Y.; Lu L.-C.; Hsu C.; YU-YUN SHAO; Lu L.-C.;Hsu C.;Yu-Yun Shao;Chao Y.;Yen C.-J.;Shih I.-L.;Hung Y.-P.;Chang C.-J.;Shen Y.-C.;Guo J.-C.;Liu T.-H.;Hsu C.-H.;Cheng A.-L.
臺大學術典藏	2020-04-10T12:15:53Z	Early alpha-foetoprotein response associated with treatment efficacy of immune checkpoint inhibitors for advanced hepatocellular carcinoma	Yu-Yun Shao;Liu T.-H.;Hsu C.;Lu L.-C.;Shen Y.-C.;Lin Z.-Z.;Cheng A.-L.;Hsu C.-H.; YU-YUN SHAO; Liu T.-H.; Hsu C.; Lu L.-C.; Shen Y.-C.; Lin Z.-Z.; Cheng A.-L.; Hsu C.-H.
臺大學術典藏	2020-04-09T09:39:09Z	Lenalidomide as second-line therapy for advanced hepatocellular carcinoma: exploration of biomarkers for treatment efficacy	Shao, Y. Y.; Chen, B. B.; Ou, D. L.; Lin, Z. Z.; Hsu, C. H.; Wang, M. J.; Cheng, A. L.; Hsu, C.
臺大學術典藏	2020-03-27T02:03:35Z	Diagnostic value of 18F-FDG-PET/CT in indeterminate infiltrative hepatic lesions in an endemic area of viral hepatitis	Cheng M.-F.;Wu Y.-W.;Kao-Lang Liu;Yen R.-F.;Wu Y.-M.;Hsu C.;Chang Y.-T.;Tzen K.-Y.;Wang H.-P.; Cheng M.-F.; Wu Y.-W.; KAO-LANG LIU; Yen R.-F.; Wu Y.-M.; Hsu C.; Chang Y.-T.; Tzen K.-Y.; Wang H.-P.
臺大學術典藏	2020-03-27T02:03:26Z	Comparison of characteristics and transarterial chemoembolization outcomes in patients with unresectable hepatocellular carcinoma and different viral etiologies	KAO-LANG LIU; Liang P.-C.; Chen C.-H.; Shih T.T.-F.; Hsu C.; Wu C.-H.; Shih I.-L.; Chen B.-B.; Chen B.-B.;Shih I.-L.;Wu C.-H.;Hsu C.;Chen C.-H.;Shih T.T.-F.;Kao-Lang Liu;Liang P.-C.
臺大學術典藏	2020-03-27T02:03:25Z	Cough with bile	Chang C.-C.; Hsu C.; KAO-LANG LIU
臺大學術典藏	2020-03-25T03:28:06Z	Grape seed proanthocyanidins protect cardiomyocytes from ischemia and reperfusion injury via Akt-NOS signaling	Vanden Hoek T.L.; Yuan C.-S.; Hamann K.J.; Sharp W.W.; WEI-TIEN CHANG; Qin Y.; Li C.-Q.; Mehendale S.R.; Hsu C.; Dossumbekova A.; Wojcik K.R.; Shao Z.-H.; Vanden Hoek T.L.;Yuan C.-S.;Hamann K.J.;WEI-TIEN CHANG;Sharp W.W.;Qin Y.;Li C.-Q.;Mehendale S.R.;Hsu C.;Dossumbekova A.;Wojcik K.R.;Shao Z.-H.
臺大學術典藏	2020-03-24T04:02:55Z	Lack of efficacy to systemic chemotherapy for treatment of metaplastic carcinoma of the breast in the modern era	Lin C.H.; Chen I.C.; Chen I.C. ;Lin C.H. ;Huang C.S. ;Lien H.C. ;Hsu C. ;Wen-Hung Kuo ;Lu Y.S. ;Cheng A.L.; Huang C.S.; Lien H.C.; Hsu C.; WEN-HUNG KUO; Lu Y.S.; Cheng A.L.
臺大學術典藏	2020-03-23T07:19:36Z	Phase II trial combining paclitaxel with 24-hour infusion cisplatin for chemotherapy-na?ve patients with locally advanced or metastatic breast carcinoma	Hsu C.;Chiun-Sheng Huang;Chao T.-Y.;Lu Y.-S.;Bu C.-F.;Chen M.M.;Chang K.-J.;Cheng A.-L.; Hsu C.; CHIUN-SHENG HUANG; Chao T.-Y.; Lu Y.-S.; Bu C.-F.; Chen M.M.; Chang K.-J.; Cheng A.-L.
臺大學術典藏	2020-03-23T07:19:32Z	A phase II trial of weekly paclitaxel and high-dose 5-fluorouracil plus leucovorin in patients with chemotherapy-pretreated metastatic breast cancer	Hsu C.; Yeh K.-H.; Wu C.-Y.; CHIUN-SHENG HUANG; Yang C.-H.; Lu Y.-S.; Hsu C.-H.; Cheng A.-L.; Lin C.-C.

顯示項目 571-580 / 881 (共89頁)
<< < 53 54 55 56 57 58 59 60 61 62 > >>
每頁顯示[10|25|50]項目